emicizumab (Hemlibra) Report issue

Biologics mAb Multi-specific Orphan Drug FDA Approved FDA First in Class Priority Review FDA
Back

Drug Pricing Summary

VA Big4

$1824.9900 - $9067.9800

VA FSS

$2711.3800 - $13560.2300

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
emicizumab 150 mg / 1 mL (1 mL INJECTION) $6282.8700 VA Big4
  • Hemlibra (1)
  • Genentech USA
    emicizumab 150 mg / 1 mL (1 mL INJECTION) $9067.9800 VA Big4
  • Hemlibra (1)
  • Genentech USA
    emicizumab 150 mg / 1 mL (1 mL INJECTION) $9492.1600 VA FSS
  • Hemlibra (1)
  • Genentech USA
    emicizumab 150 mg / 1 mL (1 mL INJECTION) $13560.2300 VA FSS
  • Hemlibra (1)
  • Genentech USA
    emicizumab 30 mg / 1 mL (1 mL INJECTION) $1824.9900 VA Big4
  • Hemlibra (1)
  • Genentech USA
    emicizumab 30 mg / 1 mL (1 mL INJECTION) $2711.3800 VA FSS
  • Hemlibra (1)
  • Genentech USA

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue